首页    期刊浏览 2024年11月08日 星期五
登录注册

文章基本信息

  • 标题:Novel Therapeutic Approach for the Management of Mood Disorders: In Vivo and In Vitro Effect of a Combination of L-Theanine, Melissa officinalis L. and Magnolia officinalis Rehder & E.H. Wilson
  • 本地全文:下载
  • 作者:Vittoria Borgonetti ; Paolo Governa ; Marco Biagi
  • 期刊名称:Nutrients
  • 电子版ISSN:2072-6643
  • 出版年度:2020
  • 卷号:12
  • 期号:6
  • 页码:1803-1817
  • DOI:10.3390/nu12061803
  • 出版社:MDPI Publishing
  • 摘要:Mood disorders represent one of the most prevalent and costly psychiatric diseases worldwide. The current therapies are generally characterized by several well-known side effects which limit their prolonged use. The use of herbal medicine for the management of several psychiatric conditions is becoming more established, as it is considered a safer support to conventional pharmacotherapy. The aim of this study was to investigate the possible anxiolytic and antidepressant activity of a fixed combination of L-theanine, Magnolia officinalis, and Melissa officinalis (TMM) in an attempt to evaluate how the multiple modulations of different physiological systems may contribute to reducing mood disorders. TMM showed an anxiolytic-like and antidepressant-like activity in vivo, which was related to a neuroprotective effect in an in vitro model of excitotoxicity. The effect of TMM was not altered by the presence of flumazenil, thus suggesting a non-benzodiazepine-like mechanism of action. On the contrary, a significant reduction in the effect was observed in animals and neuronal cells co-treated with AM251, a cannabinoid receptor type 1 (CB1) antagonist, suggesting that the endocannabinoid system may be involved in the TMM mechanism of action. In conclusion, TMM may represent a useful and safe candidate for the management of mood disorders with an innovative mechanism of action, particularly as an adjuvant to conventional therapies.
  • 关键词:mood disorders; L-theanine; excitotoxicity; neuroprotection; endocannabinoid system; CB1; flumazenil; anxiety mood disorders ; L-theanine ; excitotoxicity ; neuroprotection ; endocannabinoid system ; CB1 ; flumazenil ; anxiety
国家哲学社会科学文献中心版权所有